Innovotech (IOT) Stock Price, News & Analysis

Company Overview

Innovotech Inc. provides assay kits used in growing microbial biofilms for research purposes in Canada, the United States, and internationally. The company offers InnovoSIL, a silver periodate antimicrobial compounds for medical applications; MBEC Assay kit, a petri dish for biofilms, which are used for research and medical device testing of microbial biofilms; and AgreGuard, an antimicrobial for crop protection. It also provides antimicrobial contract research and antimicrobial testing; antimicrobial and anti-biofilm agents; antimicrobial and anti-biofilm materials; BEST assay testing; implanted medical devices; bacteriophage testing; and analytical services. The company serves customers in the areas of biofilm issues, including catheter and implant medical devices, antibiotic drug development, wound healing, paint and specialized coatings, water system antimicrobial agents, dental treatments and water line antimicrobial agents, and bacterial and fungal agricultural crop diseases, as well as disinfectants in food. Innovotech Inc. is headquartered in Edmonton, Canada.

Key Stats

• Today's Range: C$0.07 to C$0.07
• 50-Day Range: C$0.07 to C$0.09
• 52-Week Range: C$0.07 to C$0.29
• Volume: 4,000 shs
• Average Volume: 46,252 shs
• Market Capitalization: C$3.54 million
• P/E Ratio: N/A
• Dividend Yield: 10.00%
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: CVE
• Sector: Technology
• Industry: Software
• Sub-Industry: Application Software
• Current Symbol: CVE:IOT
• CIK: N/A
• Web: www.incomeopp-realty.com
• Phone: +1-780-4480585
• Fax: N/A
• Employees: 1,620
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): C($0.01)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: -29.67%
• Pretax Margin: N/A
• Return on Equity: -39.52%
• Return on Assets: -33.01%

Debt

• Debt-to-Equity Ratio: 12.55
• Current Ratio: 2.63
• Quick Ratio: 5.81

Sales & Book Value

• Annual Sales: C$3.72 million
• Price / Sales: 0.95
• Cash Flow: C$0.01 per share
• Price / Cash Flow: 10.71
• Book Value: C$0.02 per share
• Price / Book: 3.25

Miscellaneous

• Outstanding Shares: 54,438,000
• Free Float: N/A
• Market Cap: C$3.54 million
• Optionable: Not Optionable
• Beta: 2.70